Literature DB >> 19267407

Serum lipids and endometrial cancer risk: results from the HUNT-II study.

Kristina Lindemann1, Lars J Vatten, Marie Ellstrøm-Engh, Anne Eskild.   

Abstract

Obesity is a major risk factor for endometrial cancer. Still, the association of obesity-related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein (non-HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow-up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age-adjusted hazard ratio was 2.34 (95% CI: 1.04-5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79-4.05). For total serum cholesterol, low-density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. Copyright 2008 UICC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267407     DOI: 10.1002/ijc.24285

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study.

Authors:  Divya Seth; Hans Garmo; Annette Wigertz; Lars Holmberg; Niklas Hammar; Ingmar Jungner; Mats Lambe; Göran Walldius; Mieke Van Hemelrijck
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

2.  Is cholesterol a mediator of cold-induced cancer?

Authors:  Chandi C Mandal; Ankit Sharma; Mahaveer S Panwar; James A Radosevich
Journal:  Tumour Biol       Date:  2016-01-21

Review 3.  Lipid mechanisms in hallmarks of cancer.

Authors:  J Molendijk; H Robinson; Z Djuric; M M Hill
Journal:  Mol Omics       Date:  2020-02-17

Review 4.  Metabolic syndrome and endometrial cancer: a meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Dario Giugliano
Journal:  Endocrine       Date:  2013-05-03       Impact factor: 3.633

5.  Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.

Authors:  Jennifer C Melvin; Lars Holmberg; Sabine Rohrmann; Massimo Loda; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2013-01-20

6.  Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents.

Authors:  Caroline Bennette; Andrew Vickers
Journal:  BMC Med Res Methodol       Date:  2012-02-29       Impact factor: 4.615

7.  The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer.

Authors:  Haiyan Zhu; Anyang Li; Qi Jiang; Luhui Wang; Mengya Jin; Yueyao Shou
Journal:  Int J Gen Med       Date:  2022-04-11

8.  Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.

Authors:  Tatiana I Ivanova; Ludmila I Krikunova; Nikolay I Ryabchenko; Liana S Mkrtchyan; Vera A Khorokhorina; Lyubov E Salnikova
Journal:  Oxid Med Cell Longev       Date:  2015-02-09       Impact factor: 6.543

9.  Hypertriglyceridemia is frequent in endometrial cancer survivors.

Authors:  Akira Hirasawa; Kazuya Makita; Tomoko Akahane; Megumi Yokota; Wataru Yamagami; Kouji Banno; Nobuyuki Susumu; Daisuke Aoki
Journal:  Jpn J Clin Oncol       Date:  2013-09-01       Impact factor: 3.019

10.  Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.

Authors:  Pik-Fang Kho; Frederic Amant; Daniela Annibali; Katie Ashton; John Attia; Paul L Auer; Matthias W Beckmann; Amanda Black; Louise Brinton; Daniel D Buchanan; Stephen J Chanock; Chu Chen; Maxine M Chen; Timothy H T Cheng; Linda S Cook; Marta Crous-Bous; Kamila Czene; Immaculata De Vivo; Joe Dennis; Thilo Dörk; Sean C Dowdy; Alison M Dunning; Matthias Dürst; Douglas F Easton; Arif B Ekici; Peter A Fasching; Brooke L Fridley; Christine M Friedenreich; Montserrat García-Closas; Mia M Gaudet; Graham G Giles; Ellen L Goode; Maggie Gorman; Christopher A Haiman; Per Hall; Susan E Hankinson; Alexander Hein; Peter Hillemanns; Shirley Hodgson; Erling A Hoivik; Elizabeth G Holliday; David J Hunter; Angela Jones; Peter Kraft; Camilla Krakstad; Diether Lambrechts; Loic Le Marchand; Xiaolin Liang; Annika Lindblom; Jolanta Lissowska; Jirong Long; Lingeng Lu; Anthony M Magliocco; Lynn Martin; Mark McEvoy; Roger L Milne; Miriam Mints; Rami Nassir; Geoffrey Otton; Claire Palles; Loreall Pooler; Tony Proietto; Timothy R Rebbeck; Stefan P Renner; Harvey A Risch; Matthias Rübner; Ingo Runnebaum; Carlotta Sacerdote; Gloria E Sarto; Fredrick Schumacher; Rodney J Scott; V Wendy Setiawan; Mitul Shah; Xin Sheng; Xiao-Ou Shu; Melissa C Southey; Emma Tham; Ian Tomlinson; Jone Trovik; Constance Turman; Jonathan P Tyrer; David Van Den Berg; Zhaoming Wang; Nicolas Wentzensen; Lucy Xia; Yong-Bing Xiang; Hannah P Yang; Herbert Yu; Wei Zheng; Penelope M Webb; Deborah J Thompson; Amanda B Spurdle; Dylan M Glubb; Tracy A O'Mara
Journal:  Int J Cancer       Date:  2020-08-07       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.